Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASCADE: Cannabidiol in Children With Autism
NCT04520685Phase 2Active, not recruiting
- Sponsor
- University of Colorado Denver
- Start
- Dec 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Autism Spectrum Disorder (ASD), sponsored by University of Colorado Denver. Started Dec 2021; status: active, not recruiting.
02
Drugs
cannabidiol
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04520685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04520685.